Skip to content
Screener

Aspire Biopharma Holdings ASBP Q2 2026 earnings

Reported August 13, 2026 · Before market open

Revenue$63.1K
EPS-$1.00

Next report

Date not yet announced

FAQ

When did Aspire Biopharma Holdings report Q2 2026 earnings?
Aspire Biopharma Holdings (ASBP) reported Q2 2026 earnings on August 13, 2026 before market open.
What were Aspire Biopharma Holdings's Q2 2026 revenue and EPS?
Aspire Biopharma Holdings reported revenue of $63.1K and eps of $-1.00 for Q2 2026.
How did Aspire Biopharma Holdings's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 2400.0% from $-0.04.
Where can I find Aspire Biopharma Holdings's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001493152-26-036777) and the 10-Q periodic report (0001493152-26-037819) directly on SEC EDGAR. The filing index links above go to sec.gov.